日本前列腺癌临床实践指南2023年
Yasuo Kohjimoto1, Hiroji Uemura2, Masahiro Yoshida3,4
1Department of Urology, Wakayama Medical University, Wakayama, Japan.
概括
更新的"2023年日本前列腺癌临床实践指南"强调对临床问题的系统审查. 这些指南为前列腺癌管理提供了基于证据的建议.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 在瘤学瘤学.
- 基于证据的医学基于证据的医学.
背景情况:
- 日本前列腺癌临床实践指南在第四版中进行了修订.
- 修订涉及多个学术协会和患者团体,坚持"思维指南制定手册".
研究的目的:
- 为前列腺癌管理提供最新的,基于证据的建议.
- 将系统审查纳入指导方针制定过程中.
主要方法:
- 对14个临床问题 (CQ) 进行了系统性审查 (SR).
- 根据SR结果和指导方针制定小组的投票,最终确定了建议.
- 根据审查结果开发了五种算法.
主要成果:
- 通过使用定性SRs,对14个临床问题制定了建议.
- 一般陈述涵盖SR未涉及的主题,包括2016年后的调查结果.
- 该指南整合了前列腺癌护理的新证据和方法.
结论:
- 2023年指南代表了前列腺癌临床实践中的重大更新.
- 通过SRs增强了推的证据基础.
- 这些指导方针旨在通过标准化,基于证据的护理来改善患者的治疗结果.
更多相关视频
06:08A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
Published on: March 21, 2025
150
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
16.5K
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Standards of Care II
638
Nurses bear specific legal responsibilities under several federal statutes, including:
638
Standards of Care I
670
Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
670
Disorders of the Male Reproductive System
373
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
373
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
